AI assistant
Innoviva, Inc. — Director's Dealing 2011
Jun 8, 2011
32090_dirs_2011-06-08_02e14750-c128-4365-b777-8e2d7262b1ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: THERAVANCE INC (THRX)
CIK: 0001080014
Period of Report: 2011-06-06
Reporting Person: DRAZAN JEFFREY M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-06-06 | Common Stock | S | 37344 | $23.08 | Disposed | 78251 | Direct |
| 2011-06-07 | Common Stock | S | 31907 | $23.29 | Disposed | 46344 | Direct |
Footnotes
F1: Represents sales of (i) 15,000 shares held personally by the Reporting Person and (ii) 22,344 shares held by Sierra Ventures Associates VI, L.P. as nominee for the Reporting Person.
F2: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.00 to $23.23 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3: Price reflected is the weighted-average sale price for shares sold. The range of sale prices for the transactions reported was $23.25 to $23.38 per share. The Reporting Person undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.